Exhale

The official blog of the Lung Institute.

Cellular Treatment Review for Pulmonary Fibrosis

Stem Cell Treatment Review for Pulmonary Fibrosis

Chronic lung diseases come in many forms, each bringing its own set of symptoms and challenges. For those living with pulmonary fibrosis, the scaring of the lungs turns breathing and doing everyday tasks into a constant battle. It is estimated between 132,000-200,000 Americans are affected by idiopathic pulmonary fibrosis, or pulmonary fibrosis with an unknown cause.

When it comes to treating those with pulmonary fibrosis, each treatment plan is unique. While medications and supplemental oxygen may be effective for one person, they may not work as well for another. That’s why pulmonary fibrosis patients have decided to look for other treatment options to help their symptoms.

One of those treatment options is cellular therapy. Check out this cellular therapy review for pulmonary fibrosis.

What is Cellular Therapy?

Cells are the building blocks of life because they have the ability to self-renew and replicate. Adult cells are undifferentiated cells, meaning cells from one part of the body can transform their function to that of another type of tissue. Here, at the Lung Institute, we specialize in adult cellular therapy to help those with chronic lung diseases such as pulmonary fibrosis.

During the Lung Institute’s cellular therapy process, the patients’ own cells are harvested from the blood, separated and returned to the patient intravenously. Once back in the body, the cells may begin to promote healing from within the lungs.

Cellular Treatment Review for Pulmonary Fibrosis at the Lung Institute:

In this cellular therapy review for pulmonary fibrosis, you’ll hear from two of our patients about how they feel after their cellular therapys.

Joseph O – Selden, NY

Cellular Treatment Review for Pulmonary Fibrosis

“I want to thank the Lung Institute for giving me my life back. I was told by many pulmonologists that there was no cure, no hope, and it was terminal. Not anymore. Not anymore. I feel like a million dollars. I really do.”

Pulmonary fibrosis had left Joseph O struggling to do much of anything. From walking up a flight of steps to having to sit in a chair when brushing his teeth, everything was a challenge for Joseph. Finally, Joseph decided to research his options and decided to try cellular therapy. After his treatment, he noticed gradual improvement. His friends and family couldn’t believe it and thought it was a miracle.

Now, Joseph is looking to regain his stamina and get back to a normal life.

Don C – Lakewood, Ohio

Cellular Treatment Review for Pulmonary Fibrosis

“My wife was very skeptical at first, and she sees what it’s doing now and says ‘wow.’”

After 30 years of breathing in construction debris and cigarette smoke, Don C was battling both pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). As his chronic lung diseases progressed, he found himself needing supplemental oxygen around the clock. When doing basic tasks became a challenge, Don started to investigate his options. Initially, doctors suggested Don get a lung transplant, but the recovery time and life expectancy didn’t add up for him. That’s when he decided to try cellular therapy. Now, Don no longer needs oxygen and looks forward to improving his health.

For Joseph and Don, the reasons they chose cellular therapy for their pulmonary fibrosis are different. But now, they both look optimistically towards the future and plan on making the most of their improved quality of life. If you or someone you know is battling pulmonary fibrosis, COPD or interstitial lung disease, it may be time to consider the Lung Institute. For more information on cellular therapy, please contact us or call (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.